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The purpose of this study was to prepare terbinafine hydrochloride (TER) solid binary systems 
with amorphous cyclodextrin derivatives (hydroxypropyl-β-cyclodextrin (HPBCD), 
heptakis(2,6-di-O-methyl)-β-cyclodextrin (DIMEB)) by co-grinding and perform analytical 
studies. Cyclodextrin–TER complexes were prepared in the 1:1 molar ratio. The products were 
investigated for both solid phase characterization (differential scanning calorimetry (DSC), X-
ray powder diffractometry (XRPD), hot-humidity stage X-ray powder diffractometry (HOT-
XRPD), Raman spectroscopy, Fourier transform infrared spectroscopy (FT-IR)) and dissolution 
properties (dissolution studies). DSC and XRPD studies indicated that with the increasing 
grinding time the crystallinity of products gradually decreased, and the products were 
completely amorphous after 75 minutes of grinding. HOT-XRPD studies were carried out in a 
wide temperature range and revealed that product containing HPBCD remained amorphous 
with the increasing temperature, while in the case of DIMEB the complex recrystallized in a 
different crystalline phase. Raman and FT-IR spectroscopy were used to investigate the 
molecular interactions between the components. Both products presented a notable 
improvement in its dissolution rate, and the solubility of TER increased both in simulated 
gastric and intestinal fluid, depending on the dissolution medium. Co-grinding is a solvent-free 
method to prepare stable amorphous cyclodextrin complexes and improve solubility and 
dissolution ratio. This could cause enhanced biopharmaceutical properties of the active 
ingredients in solid pharmaceutical products. 
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